Clinical Trials Directory

Trials / Completed

CompletedNCT03224546

Cocaine Use Reduction and Health

Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
127 (actual)
Sponsor
William Stoops · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced cocaine use. These data will be used to change current accepted cocaine treatment endpoints and accelerate identification of therapies for cocaine use disorder.

Conditions

Interventions

TypeNameDescription
BEHAVIORALContingency ManagementSubjects will receive payments for providing cocaine negative urine samples.

Timeline

Start date
2017-09-15
Primary completion
2024-01-15
Completion
2024-01-15
First posted
2017-07-21
Last updated
2024-08-01
Results posted
2024-08-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03224546. Inclusion in this directory is not an endorsement.